Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.
Giulia FerranniniDirk De BacquerIris ErlundViveca GybergKornelia KotsevaLinda MellbinAnna NorhammarOliver SchnellJaakko TuomilehtoTerhi VihervaaraDavid WoodLars RydénPublished in: Diabetes care (2022)
Screening for dysglycemia in patients with CAD by HOMA-IR, HOMA2-ins, and HOMA2-Cpep had insufficient diagnostic performance to detect dysglycemia with reference to the yield of an OGTT, which should still be prioritized despite its practical drawbacks.